We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

140 hedge funds and large institutions have $230M invested in Viking Therapeutics in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 49 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more call options, than puts

Call options by funds: $8.28M | Put options by funds: $2.76M

21% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 14

1% more funds holding

Funds holding: 138 → 140 (+2)

1.04% less ownership

Funds ownership: 55.42% → 54.37% (-1%)

21% less capital invested

Capital invested by funds: $290M → $230M (-$60M)

31% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 49

Holders
140
Holders Change
+2
Holders Change %
+1.45%
% of All Funds
2.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
34
Reduced
49
Closed
14
Calls
$8.28M
Puts
$2.76M
Net Calls
+$5.52M
Net Calls Change
-$4.34M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$5.38M
2
DM
Deerfield Management
New York
+$2.4M
3
N
Nuveen
North Carolina
+$1.74M
4
SG Americas Securities
SG Americas Securities
New York
+$1.61M
5
Morgan Stanley
Morgan Stanley
New York
+$1.19M

Top Sellers

Rank Fund Capital Flow
1
ACH
ArrowMark Colorado Holdings
Colorado
-$3.27M
2
Two Sigma Investments
Two Sigma Investments
New York
-$2.74M
3
Millennium Management
Millennium Management
New York
-$2.52M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.07M
5
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$1.92M
Name Holding Trade Value Shares
Change 		Change in
Stake
GC
126
Grace Capital
Massachusetts
$4K – – –
LC
127
Lindbrook Capital
California
$4K – – –
TWA
128
TCI Wealth Advisors
Arizona
$3K -$2.75K -400 -44%
CFD
129
Creative Financial Designs
Indiana
$3K – – –
ASN
130
Advisory Services Network
Georgia
$3K +$3.47K +504 New
GWM
131
Geneos Wealth Management
Colorado
$2K – – –
Federated Hermes
132
Federated Hermes
Pennsylvania
$2K +$1.21K +176 +103%
Rockefeller Capital Management
133
Rockefeller Capital Management
New York
$2K +$1.38K +200 +125%
Northwestern Mutual Wealth Management
134
Northwestern Mutual Wealth Management
Wisconsin
$2K +$2.07K +300 New
FHA
135
Flagship Harbor Advisors
Massachusetts
$2K +$2.41K +350 New
CAL
136
Capital Analysts LLC
Pennsylvania
$1K – – –
FIA
137
FNY Investment Advisers
New York
$1K – – –
Millennium Management
138
Millennium Management
New York
$204 -$2.52M -365,603 -91%
SFM
139
Sphera Funds Management
Israel
– -$1.48M -205,000 Closed
Ameriprise
140
Ameriprise
Minnesota
– -$346K -47,973 Closed
WCM
141
Weld Capital Management
New York
– -$211K -29,213 Closed
ECM
142
ExodusPoint Capital Management
New York
– -$191K -26,469 Closed
Creative Planning
143
Creative Planning
Kansas
– -$166K -22,973 Closed
XM
144
XTX Markets
New York
– -$111K -15,397 Closed
VF
145
Virtu Financial
New York
– -$92K -12,761 Closed
Balyasny Asset Management
146
Balyasny Asset Management
Illinois
– -$75K -10,410 Closed
PAG
147
Private Advisor Group
New Jersey
– -$32K -4,450 Closed
Walleye Trading
148
Walleye Trading
New York
– -$11.5K -1,669 Closed
IC
149
Ikarian Capital
Texas
– -$8K -1,159 Closed
AA
150
AlphaMark Advisors
Kentucky
– -$1K -200 Closed
3 4 5
6
7

VKTX Hedge Fund Activity: Q3 2020 in Review

140 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q3 2020, worth a combined $230M — down 21% from $290M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new VKTX positions and 14 closed out — a net gain of 3 holders — while 34 added to existing stakes and 49 trimmed.

The largest buyer was State Street, adding an estimated $5.38M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $3.27M.

  • 140 institutional investors held Viking Therapeutics (VKTX) as of Q3 2020, up from 138 in Q2 2020.
  • Funds reported $230M of Viking Therapeutics stock for Q3 2020, down 21% quarter-over-quarter.
  • 17 funds opened new Viking Therapeutics positions in Q3 2020 and 14 closed out, a net change of +3 holders.
  • The largest Viking Therapeutics buyer in Q3 2020 was State Street, an estimated $5.38M added.
  • The largest Viking Therapeutics seller in Q3 2020 was ArrowMark Colorado Holdings, an estimated $3.27M sold.

Based on aggregated 13F filings for Q3 2020.